n Lorenz connect conference at April 08th, Sophia Huang, GM of Beijing BrilliantMed Pharma Tech Co., Ltd, presented on China's eSubmission and eCTD submission: Policy updates with far - reaching implications. The presentation introduced the eCTD implementation timelines, overview of China eSubmission and eCTD submission, recent announcement on eCTD implementation expansion and the impact on Chinese Pharmaceutical industry.

Previous post：Video: China eSubmission and eCTD submission: Policy Updates with far-reaching Implications Next chapter：News: China's eCTD Policy Update: Implementation Expanded from January 2025, Accelerating Digitalization of Drug Review Process

Contact

Looking ahead, we will continue to strengthen technological innovation and service upgrading, promote the healthy development of the pharmaceutical industry, and create greater value for customers. We look forward to cooperating with global customers to create brilliance together.

Room 508, Building 8, Zhongke E-commerce Valley, No. 20 Guangde Street, Beijing Economic and Technological Development Area, Beijing City
+86 15001236015
Sophia.huang@brilliantmed.cn

Submit